These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27138184)

  • 21. Comparison of usefulness of echocardiographic Doppler variables to left ventricular end-diastolic pressure in predicting future heart failure events.
    Liang HY; Cauduro SA; Pellikka PA; Bailey KR; Grossardt BR; Yang EH; Rihal C; Seward JB; Miller FA; Abraham TP
    Am J Cardiol; 2006 Mar; 97(6):866-71. PubMed ID: 16516591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Clinical and Echocardiographic Evaluation to Assess the Risk of Heart Failure.
    Potter E; Huynh Q; Haji K; Wong C; Yang H; Wright L; Marwick TH
    JACC Heart Fail; 2024 Feb; 12(2):275-286. PubMed ID: 37498272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical risk stratification optimizes value of biomarkers to predict new-onset heart failure in a community-based cohort.
    Brouwers FP; van Gilst WH; Damman K; van den Berg MP; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van der Harst P; de Boer RA
    Circ Heart Fail; 2014 Sep; 7(5):723-31. PubMed ID: 25057112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mitral L wave: a marker of pseudonormal filling and predictor of heart failure in patients with left ventricular hypertrophy.
    Lam CS; Han L; Ha JW; Oh JK; Ling LH
    J Am Soc Echocardiogr; 2005 Apr; 18(4):336-41. PubMed ID: 15846161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the energy waveform electrocardiogram to detect subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus.
    Soh CH; de Sá AGC; Potter E; Halabi A; Ascher DB; Marwick TH
    Cardiovasc Diabetol; 2024 Mar; 23(1):91. PubMed ID: 38448993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.
    Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Drouet E; Linde C; Daubert C;
    Eur J Heart Fail; 2015 Jul; 17(7):680-8. PubMed ID: 26033771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity of electrocardiographic myocardial infarction screening criteria in patients with nonischemic cardiomyopathies.
    Shah BR; Lin C; Maynard C; Bart B; Selvester RH; Shaw LK; O'Connor C; Wagner GS
    Am Heart J; 1998 Aug; 136(2):314-9. PubMed ID: 9704696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of the Agatston score = 0 to exclude ischemic cardiomyopathy in patients with heart failure.
    Abunassar JG; Yam Y; Chen L; D'Mello N; Chow BJ
    Am J Cardiol; 2011 Feb; 107(3):428-32. PubMed ID: 21257010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening to prevent heart failure (STOP-HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction.
    Murtagh G; Dawkins IR; O'Connell R; Badabhagni M; Patel A; Tallon E; O'Hanlon R; Ledwidge MT; McDonald KM
    Eur J Heart Fail; 2012 May; 14(5):480-6. PubMed ID: 22416086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline predictors of cardiac events after cardiac resynchronization therapy in patients with heart failure secondary to ischemic or nonischemic etiology.
    Soliman OI; Theuns DA; ten Cate FJ; Anwar AM; Nemes A; Vletter WB; Jordaens LJ; Geleijnse ML
    Am J Cardiol; 2007 Aug; 100(3):464-9. PubMed ID: 17659930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
    Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrocardiographic predictors of incident heart failure in men and women free from manifest cardiovascular disease (from the Atherosclerosis Risk in Communities [ARIC] study).
    Rautaharju PM; Zhang ZM; Haisty WK; Prineas RJ; Kucharska-Newton AM; Rosamond WD; Soliman EZ
    Am J Cardiol; 2013 Sep; 112(6):843-9. PubMed ID: 23768456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of mortality and hospitalization for cardiac causes in patients with heart failure and nonischemic heart disease: a subanalysis of the ALPHA study.
    Anselmino M; De Ferrari GM; Massa R; Manca L; Tritto M; Molon G; Curnis A; Devecchi P; Sarzi Braga S; Bartesaghi G; Klersy C; Accardi F; Salerno-Uriarte JA;
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S214-8. PubMed ID: 19250099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction.
    Akiyama E; Sugiyama S; Matsuzawa Y; Konishi M; Suzuki H; Nozaki T; Ohba K; Matsubara J; Maeda H; Horibata Y; Sakamoto K; Sugamura K; Yamamuro M; Sumida H; Kaikita K; Iwashita S; Matsui K; Kimura K; Umemura S; Ogawa H
    J Am Coll Cardiol; 2012 Oct; 60(18):1778-86. PubMed ID: 23040568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serial Doppler echocardiography and tissue Doppler imaging in the detection of elevated directly measured left atrial pressure in ambulant subjects with chronic heart failure.
    Ritzema JL; Richards AM; Crozier IG; Frampton CF; Melton IC; Doughty RN; Stewart JT; Eigler N; Whiting J; Abraham WT; Troughton RW
    JACC Cardiovasc Imaging; 2011 Sep; 4(9):927-34. PubMed ID: 21920328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.
    Longhi S; Quarta CC; Milandri A; Lorenzini M; Gagliardi C; Manuzzi L; Bacchi-Reggiani ML; Leone O; Ferlini A; Russo A; Gallelli I; Rapezzi C
    Amyloid; 2015; 22(3):147-55. PubMed ID: 25997105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular diastolic function assessment using time differences between mitral annular velocities and transmitral inflow velocities in patients with heart failure.
    Huang FQ; Tan RS; Sim D; Le TT; Zhong L
    Heart Lung Circ; 2015 Mar; 24(3):257-63. PubMed ID: 25445427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study).
    Ghio S; Freemantle N; Serio A; Magrini G; Scelsi L; Pasotti M; Cleland JG; Tavazzi L
    Eur J Echocardiogr; 2006 Oct; 7(5):373-8. PubMed ID: 16337208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of tricuspid annular tissue Doppler velocity in heart failure with atrial fibrillation.
    Kim H; Jung C; Yoon HJ; Park HS; Cho YK; Nam CW; Hur SH; Kim YN; Kim KB
    J Am Soc Echocardiogr; 2012 Apr; 25(4):436-43. PubMed ID: 22245051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.